Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2778275 | Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) | 2008 | 8 Pages |
Prostaglandin E2 (PGE2) exerts diverse biological effects through four G-protein-coupled cell surface receptor subtypes, EP1–4. This study's objective was to characterize EP1–4 receptor mRNA expression within pregnant guinea pig myometrium during early implantation stage (gestation day [GD] 6) and late stage gestation (GD 50) and evaluate in vitro contractile activity of receptor subtype selective agonists. Using RT-PCR, qualitative gene expression patterns of EP2, EP3, and EP4 mRNA were detected in the myometrium and remained unchanged between the gestational ages. EP1 mRNA remained undetected in pregnant tissue. In vitro contractile activity was evaluated in GD 6 and GD 50 myometrium using vehicle and EP agonists PGE2, 17-phenyl trinor PGE2, sulprostone, misoprostol, and CP-533,536. All spasmogens in pregnant myometrium were EP1/EP3 selective agonists, though likely acting via EP3 receptors in this test model. CP-533,536—a highly selective EP2 receptor agonist—and the vehicle failed to induce myometrial contraction at both gestational ages.